2196.HK
Price:
$14
Market Cap:
$58.46B
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. develops, manufactures, and sells pharmaceutical products in Mainland China and internationally. It operates in five segments: Pharmaceutical Manufacturing, Medical Devices and Medical Diagnosis, Healthcare Service, Pharmaceutical Distribution and Retail, Other Business segments. The company offers pharmaceutical products in the areas of tumor, immune modulation, metabolism, alimentary and central nervous system. It also provides medical devices and diagnostic products. In addition, the company offers health care and hospital management services. Further, it engages in retail and wholesale distribution of medicines. Shanghai Fosun Pharmaceutica...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2012-10-30
Stock Exchange
HKSE
Ticker
2196.HK
According to Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 11.76. This represents a change of -48.21% compared to the average of 22.71 of the last 4 quarters.
The mean historical PE Ratio of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. over the last ten years is 25.71. The current 11.76 PE Ratio has changed 4.47% with respect to the historical average. Over the past ten years (40 quarters), 2196.HK's PE Ratio was at its highest in in the December 2023 quarter at 161.92. The PE Ratio was at its lowest in in the June 2016 quarter at 12.45.
Average
25.71
Median
24.26
Minimum
19.12
Maximum
37.78
Discovering the peaks and valleys of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 84.06%
Maximum Annual PE Ratio = 37.78
Minimum Annual Increase = -41.72%
Minimum Annual PE Ratio = 19.12
Year | PE Ratio | Change |
---|---|---|
2024 | 23.89 | -15.04% |
2023 | 28.12 | 14.19% |
2022 | 24.63 | -7.15% |
2021 | 26.52 | -29.79% |
2020 | 37.78 | 84.06% |
2019 | 20.52 | 2.24% |
2018 | 20.08 | -41.72% |
2017 | 34.44 | 80.18% |
2016 | 19.12 | -12.93% |
2015 | 21.95 | -4.19% |
The current PE Ratio of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
25.55
5-year avg
28.19
10-year avg
25.71
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s PE Ratio is less than Shanghai Pharmaceuticals Holding Co., Ltd (15.60), less than Sino Biopharmaceutical Limited (18.42), greater than Sinopharm Group Co. Ltd. (7.52), less than WuXi Biologics (Cayman) Inc. (35.54), less than Luye Pharma Group Ltd. (14.30),
Company | PE Ratio | Market cap |
---|---|---|
15.60 | $66.04B | |
18.42 | $72.47B | |
7.52 | $57.70B | |
35.54 | $95.65B | |
14.30 | $7.30B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shanghai Fosun Pharmaceutical (Group) Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Shanghai Fosun Pharmaceutical (Group) Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Shanghai Fosun Pharmaceutical (Group) Co., Ltd.'s PE Ratio?
How is the PE Ratio calculated for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)?
What is the highest PE Ratio for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)?
What is the 3-year average PE Ratio for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)?
What is the 5-year average PE Ratio for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK)?
How does the current PE Ratio for Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (2196.HK) compare to its historical average?